{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:18:12Z","timestamp":1790338692965,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2018.01.042","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T01:29:06Z","timestamp":1517534946000},"page":"1285-1296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France"],"prefix":"10.1016","volume":"36","author":[{"given":"D.S.","family":"N'Diaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Picone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tsatsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schwarzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.vaccine.2018.01.042_b0005","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA J Am Med Assoc"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2018.01.042_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/peds.104.1.55","article-title":"Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus","volume":"104","author":"Boppana","year":"1999","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2018.01.042_b0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.vaccine.2018.01.042_b0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.01.042_b0025","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1542\/peds.2005-1142","article-title":"Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity","volume":"118","author":"Fowler","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2018.01.042_b0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/CMR.15.4.680-715.2002","article-title":"Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant","volume":"15","author":"Revello","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.042_b0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(99)70328-8","article-title":"Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?","volume":"135","author":"Fowler","year":"1999","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2018.01.042_b0040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-0528.2009.02139.x","article-title":"A 2-year study on cytomegalovirus infection during pregnancy in a French hospital","volume":"116","author":"Picone","year":"2009","journal-title":"BJOG"},{"issue":"Supplement 4(0)","key":"10.1016\/j.vaccine.2018.01.042_b0045","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2009.09.003","article-title":"Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy?: Results of a 3-year prospective study in a French hospital","volume":"46","author":"Vauloup-Fellous","year":"2009","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.01.042_b0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1007450729633","article-title":"Cytomegalovirus seroprevalence in French pregnant women: Parity and place of birth as major predictive factors","volume":"14","author":"Gratacap-Cavallier","year":"1998","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.042_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1386-6532(00)00184-0","article-title":"Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR","volume":"21","author":"Gouarin","year":"2001","journal-title":"J Clin Virol."},{"issue":"2","key":"10.1016\/j.vaccine.2018.01.042_b0060","doi-asserted-by":"crossref","first-page":"e89857","DOI":"10.1371\/journal.pone.0089857","article-title":"Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France","volume":"9","author":"N'Diaye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.01.042_b0065","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. \u00c9valuation de l\u2019int\u00e9r\u00eat du d\u00e9pistage de l\u2019infection \u00e0 cytom\u00e9galovirus chez la femme enceinte en France: Saint-Denis La Plaine, France: Agence Nationale d\u2019Accr\u00e9ditation et d\u2019\u00c9valuation en Sant\u00e9; 2004 [Available from: http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/CMV_rap.pdf"},{"key":"10.1016\/j.vaccine.2018.01.042_b0070","series-title":"Enqu\u00eate sur les infections cong\u00e9nitales \u00e0 cytom\u00e9galovirus d\u00e9tect\u00e9es pendant la grossesse ou \u00e0 la naissance en France m\u00e9tropolitaine","author":"Parent du Ch\u00e2telet","year":"2007"},{"key":"10.1016\/j.vaccine.2018.01.042_b0075","unstructured":"ClinicalTrials.gov. Search for \u201cCMV\u201d and \u201cPregnancy\u201d; 2014 [Available from: <http:\/\/clinicaltrials.gov\/ct2\/results?term=CMV+pregnancy&Search=Search>."},{"issue":"12","key":"10.1016\/j.vaccine.2018.01.042_b0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.01.042_b0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.01.042_b0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.01.042_b0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.659","article-title":"Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV","volume":"20","author":"Hyde","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2018.01.042_b0100","unstructured":"Institut National de la Statistique et des \u00c9tudes \u00e9conomiques. Recensement de la population fran\u00e7aise au 1er janvier 2011; 2014 [updated 2014\/05\/09\/16:46:49. Available from: <http:\/\/www.insee.fr\/fr\/ppp\/bases-de-donnees\/recensement\/populations-legales\/pages2013\/xls\/ensemble.xls>."},{"key":"10.1016\/j.vaccine.2018.01.042_b0105","unstructured":"Institut National des Etudes D\u00e9mographiques. Tout savoir sur la population, Les chiffres, France; 2014 [Available from: <http:\/\/www.ined.fr\/fr\/ressources-methodes\/dossiers-thematiques\/#theme-3>."},{"key":"10.1016\/j.vaccine.2018.01.042_b0110","unstructured":"Lepoutre A, Antona D, Fonteneau L, Halftermeyer-Zhou F, Baudon C, Dorl\u00e9ans F, et al. Seroprevalence of vaccine-preventable diseases and five other infectious diseases in France. Results of two national surveys 2008-2010. Bull epidemiol Hebd InVS [Internet]; 2013. p. 41\u201342. Available from: http:\/\/www.invs.sante.fr\/beh\/2013\/41-42\/2013_41-42_1.html."},{"key":"10.1016\/j.vaccine.2018.01.042_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2334-7-71","article-title":"Incidence of cytomegalovirus infection among the general population and pregnant women in the United States","volume":"7","author":"Colugnati","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.01.042_b0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2018.01.042_b0125","unstructured":"Cr\u00e9pin G. Epidemiology of maternal deaths in France, 2001\u20132006; 2010 [Available from: http:\/\/www.invs.sante.fr\/beh\/2010\/02_03\/beh_02_03_2010.pdf."},{"issue":"7251","key":"10.1016\/j.vaccine.2018.01.042_b0130","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","article-title":"Maternal age and fetal loss: population based register linkage study","volume":"320","author":"Nybo Andersen","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2018.01.042_b0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1067\/mpa.2000.103870","article-title":"Ophthalmologic findings in children with congenital cytomegalovirus infection","volume":"4","author":"Coats","year":"2000","journal-title":"J AAPOS"},{"issue":"27","key":"10.1016\/j.vaccine.2018.01.042_b0140","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.vaccine.2012.04.011","article-title":"Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus","volume":"30","author":"Dempsey","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.042_b0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.spid.2004.09.011","article-title":"Congenital cytomegalovirus infection: outcome and diagnosis","volume":"16","author":"Ross","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.042_b0150","series-title":"Congenital Cytomegalovirus Infection","first-page":"121","article-title":"How to save money: congenital CMV infection and the economy","author":"Walter","year":"2011"},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.042_b0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2009.01.040","article-title":"Improving decision analyses: parent preferences (utility values) for pediatric health outcomes","volume":"155","author":"Carroll","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2018.01.042_b0160","unstructured":"Ameli.fr. French Health Insurance website; 2013 [Available from: <http:\/\/www.ameli.fr\/accueil-de-la-ccam\/index.php>."},{"key":"10.1016\/j.vaccine.2018.01.042_b0165","unstructured":"Agence Technique de l'Information sur l'Hospitalisation. R\u00e9f\u00e9rentiel de co\u00fbts MCO 2011: Agence Technique de l'Information sur l'Hospitalisation (ATIH); 2014 [updated 2014\/05\/19\/16:58:12. Agence Technique de l'Information sur l'Hospitalisation (ATIH):[Available from: <http:\/\/www.atih.sante.fr\/referentiel-de-couts-mco-2011>."},{"issue":"6","key":"10.1016\/j.vaccine.2018.01.042_b0170","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archopht.126.6.849","article-title":"Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma","volume":"126","author":"Bramley","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.01.042_b0175","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment\u2013United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.vaccine.2018.01.042_b0180","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.1996.03540140060028","article-title":"The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"Russell","year":"1996","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2018.01.042_b0185","unstructured":"World Health Organization. WHO guide to cost-effectiveness analysis: \u00a9 World Health Organization 2003; 2003 [Available from: <http:\/\/www.who.int\/choice\/publications\/p_2003_generalised_cea.pdf>."},{"key":"10.1016\/j.vaccine.2018.01.042_b0190","series-title":"An introduction to infectious disease modelling","first-page":"109","author":"Vynnycky","year":"2010"},{"issue":"10","key":"10.1016\/j.vaccine.2018.01.042_b0195","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/587695","article-title":"Humoral and cellular immune responses to a hepatitis B vaccine booster 15\u201318 years after neonatal immunization","volume":"197","author":"Lu","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2018.01.042_b0200","unstructured":"Institut National de la Statistique et des \u00c9tudes \u00e9conomiques. Immigr\u00e9s et descendants d'immigr\u00e9s en France 2012 [Available from: <http:\/\/www.insee.fr\/fr\/publications-et-services\/sommaire.asp?codesage=IMMFRA12>."},{"issue":"12","key":"10.1016\/j.vaccine.2018.01.042_b0205","doi-asserted-by":"crossref","first-page":"e52303","DOI":"10.1371\/journal.pone.0052303","article-title":"Low rate of pandemic A\/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study","volume":"7","author":"Launay","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.042_b0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0272989X02239651","article-title":"Economic evaluation of vaccination programs: the impact of herd-immunity","volume":"23","author":"Brisson","year":"2003","journal-title":"Med Decis Making"},{"key":"10.1016\/j.vaccine.2018.01.042_b0215","unstructured":"World Health Organization. WHO guide for standardization of economic evaluations of immunization programmes 2008 [Available from: <http:\/\/whqlibdoc.who.int\/hq\/2008\/WHO_IVB_08.14_eng.pdf>."},{"issue":"11","key":"10.1016\/j.vaccine.2018.01.042_b0220","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988\u20132004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.042_b0225","unstructured":"Legifrance.gouv.fr. Titre iv: interruption de grossesse pratiqu\u00e9e pour motif m\u00e9dical: R\u00e9publique Fran\u00e7aise; 2011 [Available from: <http:\/\/www.legifrance.gouv.fr\/affichCodeArticle.do;jsessionid=A8FC9D89895232EC3FBAE14CCCC754CD.tpdjo06v_1?cidTexte=LEGITEXT000006072665&idArticle=LEGIARTI000024325480&dateTexte=20141004&categorieLien=id#LEGIARTI000024325480>."},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.042_b0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","article-title":"Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force","volume":"17","author":"Sullivan","year":"2014","journal-title":"Value Heal J Int Soc Pharmacoeconom Outcomes Res"},{"key":"10.1016\/j.vaccine.2018.01.042_b0235","unstructured":"INSEE. Esp\u00e9rence de vie \u00e0 divers \u00e2ge, France hors Mayotte: Institut National de la statistique et des \u00e9tudes \u00e9conomiques (INSEE). 2013 [Available from: <http:\/\/www.insee.fr\/fr\/themes\/detail.asp?reg_id=0&ref_id=bilan-demo&page=donnees-detaillees\/bilan-demo\/pop_age3d.htm>."},{"issue":"9","key":"10.1016\/j.vaccine.2018.01.042_b0240","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-0528.2007.01308.x","article-title":"Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection","volume":"114","author":"Jacquemard","year":"2007","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.vaccine.2018.01.042_b0245","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/430172","article-title":"Risk of congenital cytomegalovirus infection","volume":"40","author":"Cannon","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.042_b0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1651-2227.1982.tb09380.x","article-title":"Primary and secondary maternal cytomegalovirus infections and their relation to congenital infection. Analysis of maternal sera","volume":"71","author":"Ahlfors","year":"1982","journal-title":"Acta Paediatr Scand"},{"issue":"7","key":"10.1016\/j.vaccine.2018.01.042_b0255","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1471-0528.2008.01728.x","article-title":"Managing primary CMV infection in pregnancy","volume":"115","author":"Bhide","year":"2008","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.vaccine.2018.01.042_b0260","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.289.8.1008","article-title":"Maternal immunity and prevention of congenital cytomegalovirus infection","volume":"289","author":"Fowler","year":"2003","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2018.01.042_b0265","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00431-002-1115-5","article-title":"Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature","volume":"162","author":"Gaytant","year":"2003","journal-title":"Eur J Pediatr."},{"issue":"4","key":"10.1016\/j.vaccine.2018.01.042_b0270","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1471-0528.1980.tb04546.x","article-title":"A prospective study of primary cytomegalovirus infection in pregnant women","volume":"87","author":"Griffiths","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2018.01.042_b0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-9378(96)70401-5","article-title":"Congenital cytomegalovirus infection: a long-standing problem still seeking a solution","volume":"174","author":"Hagay","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.01.042_b0280","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1542\/peds.74.4.493","article-title":"Primary cytomegalovirus infection in adolescent pregnancy","volume":"74","author":"Kumar","year":"1984","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2018.01.042_b0285","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0002-9378(88)90252-9","article-title":"Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants","volume":"158","author":"Yow","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.01.042_b0290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2018.01.042_b0295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.vaccine.2018.01.042_b0300","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archpedi.1982.03970460026006","article-title":"The outcome in children with congenital cytomegalovirus infection. A longitudinal follow-up study","volume":"136","author":"Saigal","year":"1982","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1016\/j.vaccine.2018.01.042_b0305","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.qco.0000168385.39390.1b","article-title":"Cytomegalovirus","volume":"18","author":"Griffiths","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.01.042_b0310","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpeds.2005.09.003","article-title":"Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity","volume":"148","author":"Ross","year":"2006","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2018.01.042_b0315","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365549950163969","article-title":"Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature","volume":"31","author":"Ahlfors","year":"1999","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.01.042_b0320","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006254-200204000-00024","article-title":"Congenital cytomegalovirus infection: review of the epidemiology and outcome","volume":"57","author":"Gaytant","year":"2002","journal-title":"Obstet Gynecol Surv"},{"issue":"9","key":"10.1016\/j.vaccine.2018.01.042_b0325","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/adc.66.9.1068","article-title":"Outcome of confirmed symptomatic congenital cytomegalovirus infection","volume":"66","author":"Ramsay","year":"1991","journal-title":"Arch Dis Child"},{"issue":"7","key":"10.1016\/j.vaccine.2018.01.042_b0330","doi-asserted-by":"crossref","first-page":"M470","DOI":"10.1093\/gerona\/57.7.M470","article-title":"The influence of intellectual disability on life expectancy","volume":"57","author":"Bittles","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2018.01.042_b0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09286580601139212","article-title":"Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions","volume":"14","author":"Langelaan","year":"2007","journal-title":"Ophthalmic Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T20:02:18Z","timestamp":1660420938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18300914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X18300914"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}